Literature DB >> 26987082

CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Deborah Dowell1, Tamara M Haegerich, Roger Chou.   

Abstract

This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or continue opioids for chronic pain; 2) opioid selection, dosage, duration, follow-up, and discontinuation; and 3) assessing risk and addressing harms of opioid use. CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework, and recommendations are made on the basis of a systematic review of the scientific evidence while considering benefits and harms, values and preferences, and resource allocation. CDC obtained input from experts, stakeholders, the public, peer reviewers, and a federally chartered advisory committee. It is important that patients receive appropriate pain treatment with careful consideration of the benefits and risks of treatment options. This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death. CDC has provided a checklist for prescribing opioids for chronic pain (http://stacks.cdc.gov/view/cdc/38025) as well as a website (http://www.cdc.gov/drugoverdose/prescribingresources.html) with additional tools to guide clinicians in implementing the recommendations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26987082     DOI: 10.15585/mmwr.rr6501e1

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  815 in total

1.  Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck.

Authors:  Brent A Metfessel; Michelle D Mentel; Amy Phanel; Mary Ann Dimartino; Mureen Allen; Samuel Ho
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

2.  Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy.

Authors:  Michele Buonora; Hector R Perez; Moonseong Heo; Chinazo O Cunningham; Joanna L Starrels
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

3.  Evaluation of opioid use among patients with back disorders and arthritis.

Authors:  Corey J Hayes; Nalin Payakachat; Chenghui Li
Journal:  Qual Life Res       Date:  2018-07-23       Impact factor: 4.147

4.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

5.  Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices.

Authors:  Payel Roy; Angela H Jackson; Jeffrey Baxter; Belle Brett; Michael Winter; Ilana Hardesty; Daniel P Alford
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

6.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

Review 7.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

8.  Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Authors:  S C Kim; N Choudhry; J M Franklin; K Bykov; M Eikermann; J Lii; M A Fischer; B T Bateman
Journal:  Osteoarthritis Cartilage       Date:  2017-04-19       Impact factor: 6.576

9.  Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.

Authors:  Kenneth Hu; Mary Barna Bridgeman
Journal:  P T       Date:  2018-10

10.  Emergency department provider and facility variation in opioid prescriptions for discharged patients.

Authors:  Michael J Ward; Diwas Kc; Cathy A Jenkins; Dandan Liu; Amit Padaki; Jesse M Pines
Journal:  Am J Emerg Med       Date:  2018-07-31       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.